Filed: 11/10/2025ACC: 0001819257-25-000002
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 24 equity positions with a total reported market value of $373.86M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
24
Positions
$373.86M
Total AUM (reported)
21.69M
Total Shares
Allocation by class
SHS$193.20M51.7%
COM$68.31M18.3%
COM PAR $.01$47.00M12.6%
COM NEW$41.02M11.0%
SPONSORED ADS$12.89M3.4%
SPONSORED ADR$11.43M3.1%
Portfolio Concentration
Top 3$250.24M66.9%
4–10$69.62M18.6%
11–25$54.00M14.4%
Top 3 weight
66.9%
Top 10 weight
85.6%
Voting Authority Distribution
Total shares with voting rights: 20.33M
Sole
Full voting authority
20.33M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole24
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings24
Rows:
ROIVANT SCIENCES LTD
SOLEShares12.48M
TypeSH
Market value$188.82M
50.51%
Sole
12.48M
Shared
0.00
None
0.00
INSMED INC
SOLEShares326.40K
TypeSH
Market value$47.00M
12.57%
Sole
326.40K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.01M
TypeSH
Market value$14.41M
3.85%
Sole
1.01M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares151.83K
TypeSH
Market value$12.89M
3.45%
Sole
0.00
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares121K
TypeSH
Market value$11.59M
3.10%
Sole
121K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares15.50K
TypeSH
Market value$11.43M
3.06%
Sole
15.50K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares400K
TypeSH
Market value$9.10M
2.43%
Sole
400K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares345.38K
TypeSH
Market value$8.62M
2.30%
Sole
345.38K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares715K
TypeSH
Market value$8.36M
2.24%
Sole
715K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares104.26K
TypeSH
Market value$7.64M
2.04%
Sole
104.26K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares133.83K
TypeSH
Market value$5.37M
1.44%
Sole
133.83K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares92.59K
TypeSH
Market value$5.24M
1.40%
Sole
92.59K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares250.84K
TypeSH
Market value$5.13M
1.37%
Sole
250.84K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares100K
TypeSH
Market value$4.94M
1.32%
Sole
0.00
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares125K
TypeSH
Market value$4.92M
1.32%
Sole
0.00
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares74K
TypeSH
Market value$4.89M
1.31%
Sole
74K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares75K
TypeSH
Market value$4.38M
1.17%
Sole
0.00
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares316.31K
TypeSH
Market value$4.30M
1.15%
Sole
0.00
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares437.24K
TypeSH
Market value$4.04M
1.08%
Sole
437.24K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares2.98M
TypeSH
Market value$3.70M
0.99%
Sole
2.98M
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares135.18K
TypeSH
Market value$3.46M
0.93%
Sole
0.00
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$1.27M
0.34%
Sole
0.00
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares349.32K
TypeSH
Market value$1.20M
0.32%
Sole
0.00
Shared
0.00
None
0.00
GERON CORP
SOLEShares845K
TypeSH
Market value$1.16M
0.31%
Sole
845K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 12.48M | SH | $188.82M 50.51% | 12.48M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 326.40K | SH | $47.00M 12.57% | 326.40K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.01M | SH | $14.41M 3.85% | 1.01M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 151.83K | SH | $12.89M 3.45% | 0.00 | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 121K | SH | $11.59M 3.10% | 121K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 15.50K | SH | $11.43M 3.06% | 15.50K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 400K | SH | $9.10M 2.43% | 400K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 345.38K | SH | $8.62M 2.30% | 345.38K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 715K | SH | $8.36M 2.24% | 715K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 104.26K | SH | $7.64M 2.04% | 104.26K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 133.83K | SH | $5.37M 1.44% | 133.83K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 92.59K | SH | $5.24M 1.40% | 92.59K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 250.84K | SH | $5.13M 1.37% | 250.84K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 100K | SH | $4.94M 1.32% | 0.00 | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 125K | SH | $4.92M 1.32% | 0.00 | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 74K | SH | $4.89M 1.31% | 74K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 75K | SH | $4.38M 1.17% | 0.00 | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 316.31K | SH | $4.30M 1.15% | 0.00 | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 437.24K | SH | $4.04M 1.08% | 437.24K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 2.98M | SH | $3.70M 0.99% | 2.98M | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 135.18K | SH | $3.46M 0.93% | 0.00 | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 100K | SH | $1.27M 0.34% | 0.00 | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 349.32K | SH | $1.20M 0.32% | 0.00 | 0.00 | 0.00 |
GERON CORPSOLE | COM | 845K | SH | $1.16M 0.31% | 845K | 0.00 | 0.00 |